Apyx Medical PE Ratio 2010-2025 | APYX
Current and historical p/e ratio for Apyx Medical (APYX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Apyx Medical PE ratio as of May 15, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Apyx Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-15 | 1.48 | 0.00 | |
| 2025-03-31 | 1.37 | $-0.55 | 0.00 |
| 2024-12-31 | 1.58 | $-0.67 | 0.00 |
| 2024-09-30 | 1.24 | $-0.83 | 0.00 |
| 2024-06-30 | 1.34 | $-0.82 | 0.00 |
| 2024-03-31 | 1.36 | $-0.66 | 0.00 |
| 2023-12-31 | 2.62 | $-0.54 | 0.00 |
| 2023-09-30 | 3.20 | $-0.43 | 0.00 |
| 2023-06-30 | 5.03 | $-0.47 | 0.00 |
| 2023-03-31 | 2.88 | $-0.60 | 0.00 |
| 2022-12-31 | 2.34 | $-0.67 | 0.00 |
| 2022-09-30 | 4.49 | $-0.56 | 0.00 |
| 2022-06-30 | 5.86 | $-0.51 | 0.00 |
| 2022-03-31 | 6.53 | $-0.47 | 0.00 |
| 2021-12-31 | 12.82 | $-0.44 | 0.00 |
| 2021-09-30 | 13.85 | $-0.42 | 0.00 |
| 2021-06-30 | 10.31 | $-0.41 | 0.00 |
| 2021-03-31 | 9.66 | $-0.43 | 0.00 |
| 2020-12-31 | 7.20 | $-0.35 | 0.00 |
| 2020-09-30 | 4.71 | $-0.47 | 0.00 |
| 2020-06-30 | 5.55 | $-0.49 | 0.00 |
| 2020-03-31 | 3.59 | $-0.48 | 0.00 |
| 2019-12-31 | 8.46 | $-0.56 | 0.00 |
| 2019-09-30 | 6.77 | $-0.52 | 0.00 |
| 2019-06-30 | 6.72 | $1.59 | 4.23 |
| 2019-03-31 | 6.31 | $1.71 | 3.69 |
| 2018-12-31 | 6.48 | $1.82 | 3.56 |
| 2018-09-30 | 7.10 | $1.91 | 3.72 |
| 2018-06-30 | 4.35 | $-0.11 | 0.00 |
| 2018-03-31 | 2.97 | $-0.14 | 0.00 |
| 2017-12-31 | 2.60 | $-0.17 | 0.00 |
| 2017-09-30 | 3.38 | $-0.18 | 0.00 |
| 2017-06-30 | 2.47 | $-0.18 | 0.00 |
| 2017-03-31 | 2.67 | $-0.16 | 0.00 |
| 2016-12-31 | 3.59 | $-0.17 | 0.00 |
| 2016-09-30 | 5.21 | $-0.18 | 0.00 |
| 2016-06-30 | 1.64 | $-0.20 | 0.00 |
| 2016-03-31 | 1.67 | $-0.24 | 0.00 |
| 2015-12-31 | 2.10 | $0.40 | 5.25 |
| 2015-09-30 | 1.95 | $0.06 | 32.50 |
| 2015-06-30 | 2.79 | $-0.05 | 0.00 |
| 2015-03-31 | 2.39 | $-0.06 | 0.00 |
| 2014-12-31 | 3.68 | $-1.18 | 0.00 |
| 2014-09-30 | 3.99 | $-0.93 | 0.00 |
| 2014-06-30 | 3.63 | $-0.78 | 0.00 |
| 2014-03-31 | 3.90 | $-0.77 | 0.00 |
| 2013-12-31 | 2.15 | $-0.24 | 0.00 |
| 2013-09-30 | 2.82 | $-0.08 | 0.00 |
| 2013-06-30 | 2.95 | $-0.06 | 0.00 |
| 2013-03-31 | 3.30 | $0.01 | 0.00 |
| 2012-12-31 | 2.42 | $0.04 | 60.50 |
| 2012-09-30 | 3.60 | $-0.03 | 0.00 |
| 2012-06-30 | 2.39 | $-0.03 | 0.00 |
| 2012-03-31 | 2.70 | $-0.02 | 0.00 |
| 2011-12-31 | 2.12 | 0 | 0.00 |
| 2011-09-30 | 2.92 | $-0.03 | 0.00 |
| 2011-06-30 | 2.61 | $-0.03 | 0.00 |
| 2011-03-31 | 3.10 | $-0.05 | 0.00 |
| 2010-12-31 | 3.28 | $-0.09 | 0.00 |
| 2010-09-30 | 2.16 | $-0.01 | 0.00 |
| 2010-06-30 | 2.98 | $-0.01 | 0.00 |
| 2010-03-31 | 6.25 | 0 | 0.00 |
| 2009-12-31 | 7.81 | $0.03 | 260.33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.053B | $0.048B |
| Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $223.673B | 26.90 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.454B | 30.83 |
| EssilorLuxottica (ESLOY) | France | $127.910B | 0.00 |
| Medtronic (MDT) | Ireland | $108.054B | 15.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.940B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.883B | 26.67 |
| ResMed (RMD) | United States | $36.216B | 27.20 |
| GE HealthCare Technologies (GEHC) | United States | $33.352B | 15.84 |
| Agilent Technologies (A) | United States | $31.795B | 21.00 |
| Terumo (TRUMY) | Japan | $28.308B | 36.77 |
| Insulet (PODD) | United States | $22.619B | 88.79 |
| Koninklijke Philips (PHG) | Netherlands | $22.446B | 16.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.861B | 12.11 |
| Baxter (BAX) | United States | $15.559B | 11.62 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.250B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.641B | 22.45 |
| Lantheus Holdings (LNTH) | United States | $5.453B | 13.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.220B | 18.85 |
| Perrigo (PRGO) | Ireland | $3.576B | 9.06 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.449B | 15.02 |
| ICU Medical (ICUI) | United States | $3.346B | 24.67 |
| Envista Holdings (NVST) | United States | $3.039B | 25.25 |
| QuidelOrtho (QDEL) | United States | $2.269B | 15.60 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.92 |
| AtriCure (ATRC) | United States | $1.597B | 0.00 |
| Neogen (NEOG) | United States | $1.385B | 17.72 |
| AdaptHealth (AHCO) | United States | $1.200B | 12.19 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.150B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.047B | 0.00 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.946B | 12.10 |
| Evolus (EOLS) | United States | $0.644B | 0.00 |
| CeriBell (CBLL) | United States | $0.595B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.585B | 0.00 |
| Owens & Minor (OMI) | United States | $0.541B | 4.49 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.444B | 0.00 |
| Surmodics (SRDX) | United States | $0.399B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.350B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.341B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.307B | 11.29 |
| Sanuwave Health (SNWV) | United States | $0.293B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.283B | 50.40 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Verano Holdings (VRNOF) | United States | $0.261B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.259B | 0.00 |
| ZimVie (ZIMV) | United States | $0.243B | 11.04 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.229B | 0.00 |
| Biote (BTMD) | United States | $0.216B | 6.06 |
| Brainsway (BWAY) | Israel | $0.194B | 51.35 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.38 |
| Quanterix (QTRX) | United States | $0.166B | 0.00 |
| Organigram Global (OGI) | Canada | $0.163B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.18 |
| Exagen (XGN) | United States | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.118B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.64 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.84 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |